O	0	10	Mechanisms	Mechanism	NNS	B-NP
O	11	13	of	of	IN	B-PP
B-Cell	14	22	pericyte	pericyte	NN	B-NP
O	23	34	recruitment	recruitment	NN	I-NP
O	35	37	in	in	IN	B-PP
B-Cancer	38	44	tumour	tumour	NN	B-NP
O	45	57	angiogenesis	angiogenesis	NN	I-NP
O	57	58	:	:	:	O
O	59	60	a	a	DT	B-NP
O	61	64	new	new	JJ	I-NP
O	65	69	role	role	NN	I-NP
O	70	73	for	for	IN	B-PP
O	74	92	metalloproteinases	metalloproteinas	NNS	B-NP
O	92	93	.	.	.	O

B-Cell	94	103	Pericytes	Pericyte	NNS	B-NP
O	104	109	occur	occur	VBP	B-VP
O	110	112	in	in	IN	B-PP
B-Multi-tissue_structure	113	119	tumour	tumour	NN	B-NP
I-Multi-tissue_structure	120	125	blood	blood	NN	I-NP
I-Multi-tissue_structure	126	133	vessels	vessel	NNS	I-NP
O	134	137	and	and	CC	O
O	138	141	are	be	VBP	B-VP
O	142	150	critical	critical	JJ	B-ADJP
O	151	154	for	for	IN	B-PP
O	155	158	the	the	DT	B-NP
O	159	170	development	development	NN	I-NP
O	171	173	of	of	IN	B-PP
O	174	175	a	a	DT	B-NP
O	176	186	functional	functional	JJ	I-NP
B-Anatomical_system	187	195	vascular	vascular	JJ	I-NP
I-Anatomical_system	196	203	network	network	NN	I-NP
O	203	204	.	.	.	O

O	205	214	Targeting	Target	VBG	B-VP
B-Cell	215	221	tumour	tumour	NN	B-NP
I-Cell	222	231	pericytes	pericyte	NNS	I-NP
O	232	234	is	be	VBZ	B-VP
O	235	236	a	a	DT	B-NP
O	237	246	promising	promising	JJ	I-NP
O	247	251	anti	anti	AFX	I-NP
O	251	252	-	-	HYPH	I-NP
O	252	262	angiogenic	angiogenic	JJ	I-NP
O	263	270	therapy	therapy	NN	I-NP
O	271	274	but	but	CC	O
O	275	283	requires	require	VBZ	B-VP
O	284	295	identifying	identify	VBG	I-VP
O	296	299	the	the	DT	B-NP
O	300	310	mechanisms	mechanism	NNS	I-NP
O	311	313	of	of	IN	B-PP
O	314	319	their	their	PRP$	B-NP
O	320	331	recruitment	recruitment	NN	I-NP
O	332	334	in	in	IN	B-PP
B-Cancer	335	341	tumour	tumour	NN	B-NP
O	342	345	and	and	CC	O
O	346	356	addressing	address	VBG	B-VP
O	357	364	whether	whether	IN	B-SBAR
O	365	370	these	these	DT	B-NP
O	371	381	mechanisms	mechanism	NNS	I-NP
O	382	385	can	can	MD	B-VP
O	386	388	be	be	VB	I-VP
O	389	400	selectively	selectively	RB	I-VP
O	401	410	harnessed	harness	VBN	I-VP
O	410	411	.	.	.	O

O	412	417	Among	Among	IN	B-PP
O	418	421	the	the	DT	B-NP
O	422	430	pathways	pathway	NNS	I-NP
O	431	439	involved	involve	VBN	B-VP
O	440	442	in	in	IN	B-PP
B-Cell	443	451	pericyte	pericyte	NN	B-NP
O	452	463	recruitment	recruitment	NN	I-NP
O	464	470	during	during	IN	B-PP
B-Developing_anatomical_structure	471	480	embryonic	embryonic	JJ	B-NP
O	481	492	development	development	NN	I-NP
O	492	493	,	,	,	O
O	494	497	the	the	DT	B-NP
O	498	510	contribution	contribution	NN	I-NP
O	511	513	of	of	IN	B-PP
O	514	522	platelet	platelet	NN	B-NP
O	522	523	-	-	HYPH	O
O	523	530	derived	derive	VBN	B-NP
O	531	537	growth	growth	NN	I-NP
O	538	544	factor	factor	NN	I-NP
O	545	546	B	B	NN	I-NP
O	547	550	and	and	CC	O
O	551	562	sphingosine	sphingosine	NN	B-NP
O	563	564	1	1	CD	I-NP
O	564	565	-	-	HYPH	I-NP
O	565	574	phosphate	phosphate	NN	I-NP
O	575	577	is	be	VBZ	B-VP
O	578	587	confirmed	confirm	VBN	I-VP
O	588	590	in	in	IN	B-PP
B-Cancer	591	597	tumour	tumour	NN	B-NP
O	598	610	angiogenesis	angiogenesis	NN	I-NP
O	610	611	.	.	.	O

O	612	615	The	The	DT	B-NP
O	616	622	effect	effect	NN	I-NP
O	623	625	of	of	IN	B-PP
O	626	638	angiopoietin	angiopoietin	NN	B-NP
O	639	640	1	1	CD	I-NP
O	641	648	depends	depend	VBZ	B-VP
O	649	651	on	on	IN	B-PP
O	652	655	the	the	DT	B-NP
B-Cancer	656	662	tumour	tumour	NN	I-NP
O	663	668	model	model	NN	I-NP
O	668	669	.	.	.	O

O	670	682	Transforming	Transform	VBG	B-NP
O	683	689	growth	growth	NN	I-NP
O	690	696	factor	factor	NN	I-NP
O	696	697	-	-	HYPH	B-NP
O	697	702	beta1	beta1	NN	I-NP
O	703	711	enhances	enhance	VBZ	B-VP
B-Cancer	712	718	tumour	tumour	NN	B-NP
O	719	734	vascularization	vascularization	NN	I-NP
O	735	738	and	and	CC	O
B-Tissue	739	750	microvessel	microvessel	NN	B-NP
O	751	761	maturation	maturation	NN	I-NP
O	761	762	.	.	.	O

O	763	769	Recent	Recent	JJ	B-NP
O	770	777	reports	report	NNS	I-NP
O	778	785	suggest	suggest	VBP	B-VP
O	786	787	a	a	DT	B-NP
O	788	801	participation	participation	NN	I-NP
O	802	804	of	of	IN	B-PP
O	805	811	matrix	matrix	NN	B-NP
O	812	830	metalloproteinases	metalloproteinas	NNS	I-NP
O	831	832	(	(	(	O
O	832	835	MMP	MMP	NN	B-NP
O	835	836	)	)	)	O
O	837	839	in	in	IN	B-PP
B-Cell	840	846	tumour	tumour	NN	B-NP
I-Cell	847	855	pericyte	pericyte	NN	I-NP
O	856	867	recruitment	recruitment	NN	I-NP
O	868	872	that	that	WDT	B-NP
O	873	875	is	be	VBZ	B-VP
O	876	886	consistent	consistent	JJ	B-ADJP
O	887	891	with	with	IN	B-PP
O	892	895	the	the	DT	B-NP
O	896	902	effect	effect	NN	I-NP
O	903	905	of	of	IN	B-PP
O	906	913	certain	certain	JJ	B-NP
O	914	918	MMPs	MMP	NNS	I-NP
O	919	921	in	in	IN	B-PP
O	922	925	the	the	DT	B-NP
O	926	937	development	development	NN	I-NP
O	938	940	of	of	IN	B-PP
B-Tissue	941	957	microvasculature	microvasculature	NN	B-NP
O	958	960	in	in	IN	B-PP
B-Developing_anatomical_structure	961	970	embryonic	embryonic	JJ	B-NP
O	971	982	development	development	NN	I-NP
O	983	986	and	and	CC	B-PP
O	987	989	in	in	IN	B-PP
O	990	992	in	in	FW	B-NP
O	993	998	vitro	vitro	FW	I-NP
O	999	1005	models	model	NNS	I-NP
O	1006	1008	of	of	IN	B-PP
B-Multi-tissue_structure	1009	1017	vascular	vascular	JJ	B-NP
O	1018	1029	remodelling	remodelling	NN	I-NP
O	1029	1030	.	.	.	O

O	1031	1035	Here	Here	RB	B-ADVP
O	1035	1036	,	,	,	O
O	1037	1039	we	we	PRP	B-NP
O	1040	1047	discuss	discuss	VBP	B-VP
O	1048	1051	the	the	DT	B-NP
O	1052	1063	possibility	possibility	NN	I-NP
O	1064	1067	for	for	IN	B-PP
O	1068	1072	MMPs	MMP	NNS	B-NP
O	1073	1075	to	to	TO	B-VP
O	1076	1086	contribute	contribute	VB	I-VP
O	1087	1089	to	to	TO	I-VP
B-Cell	1090	1098	pericyte	pericyte	VB	I-VP
O	1099	1110	recruitment	recruitment	NN	B-NP
O	1111	1113	at	at	IN	B-PP
O	1114	1117	six	six	CD	B-NP
O	1118	1124	levels	level	NNS	I-NP
O	1124	1125	:	:	:	O
O	1126	1127	(	(	(	B-LST
O	1127	1128	1	1	LS	I-LST
O	1128	1129	)	)	)	O
O	1130	1136	direct	direct	JJ	B-NP
O	1137	1146	promotion	promotion	NN	I-NP
O	1147	1149	of	of	IN	B-PP
B-Cell	1150	1158	pericyte	pericyte	NN	B-NP
O	1159	1167	invasion	invasion	NN	I-NP
O	1168	1170	by	by	IN	B-PP
B-Cellular_component	1171	1184	extracellular	extracellular	JJ	B-NP
I-Cellular_component	1185	1191	matrix	matrix	NN	I-NP
O	1192	1203	degradation	degradation	NN	I-NP
O	1203	1204	;	;	:	O
O	1205	1206	(	(	(	B-LST
O	1206	1207	2	2	LS	I-LST
O	1207	1208	)	)	)	O
O	1209	1220	stimulation	stimulation	NN	B-NP
O	1221	1223	of	of	IN	B-PP
B-Cell	1224	1232	pericyte	pericyte	NN	B-NP
O	1233	1246	proliferation	proliferation	NN	I-NP
O	1247	1250	and	and	CC	I-NP
O	1251	1261	protection	protection	NN	I-NP
O	1262	1269	against	against	IN	B-PP
O	1270	1279	apoptosis	apoptosis	NN	B-NP
O	1280	1282	by	by	IN	B-PP
O	1283	1295	modification	modification	NN	B-NP
O	1296	1298	of	of	IN	B-PP
O	1299	1302	the	the	DT	B-NP
B-Cellular_component	1303	1306	ECM	ECM	NN	I-NP
O	1306	1307	;	;	:	O
O	1308	1309	(	(	(	B-LST
O	1309	1310	3	3	LS	I-LST
O	1310	1311	)	)	)	O
O	1312	1322	activation	activation	NN	B-NP
O	1323	1325	of	of	IN	B-PP
B-Cell	1326	1335	pericytes	pericyte	NNS	B-NP
O	1336	1343	through	through	IN	B-PP
O	1344	1347	the	the	DT	B-NP
O	1348	1355	release	release	NN	I-NP
O	1356	1358	of	of	IN	B-PP
O	1359	1365	growth	growth	NN	B-NP
O	1366	1372	factor	factor	NN	I-NP
O	1373	1378	bound	bind	VBD	B-VP
O	1379	1381	to	to	TO	B-PP
O	1382	1385	the	the	DT	B-NP
B-Cellular_component	1386	1389	ECM	ECM	NN	I-NP
O	1389	1390	;	;	:	O
O	1391	1392	(	(	(	B-LST
O	1392	1393	4	4	LS	I-LST
O	1393	1394	)	)	)	O
O	1395	1410	transactivation	transactivation	NN	B-NP
O	1411	1413	of	of	IN	B-PP
O	1414	1424	angiogenic	angiogenic	JJ	B-NP
B-Cellular_component	1425	1429	cell	cell	NN	I-NP
I-Cellular_component	1430	1437	surface	surface	NN	I-NP
O	1438	1446	receptor	receptor	NN	I-NP
O	1446	1447	;	;	:	O
O	1448	1449	(	(	(	B-LST
O	1449	1450	5	5	LS	I-LST
O	1450	1451	)	)	)	O
O	1452	1463	propagation	propagation	NN	B-NP
O	1464	1466	of	of	IN	B-PP
O	1467	1477	angiogenic	angiogenic	JJ	B-NP
O	1478	1488	signalling	signalling	NN	I-NP
O	1489	1491	as	as	IN	B-PP
O	1492	1500	cofactor	cofactor	NN	B-NP
O	1500	1501	;	;	:	O
O	1502	1505	and	and	CC	O
O	1506	1507	(	(	(	O
O	1507	1508	6	6	CD	O
O	1508	1509	)	)	)	O
O	1510	1521	recruitment	recruitment	NN	B-NP
O	1522	1524	of	of	IN	B-PP
B-Cell	1525	1529	bone	bone	NN	B-NP
I-Cell	1530	1536	marrow	marrow	NN	I-NP
I-Cell	1536	1537	-	-	HYPH	B-NP
I-Cell	1537	1544	derived	derive	VBN	I-NP
I-Cell	1545	1549	stem	stem	NN	I-NP
I-Cell	1550	1555	cells	cell	NNS	I-NP
O	1555	1556	.	.	.	O

